POINT OF CARE TEST FOR THE DETECTION OF EXPOSURE TO HEV IMMUNOGLOBULIN A (IGA)
The present invention provides a point of care test ("POCT") for detecting IgA in a subject that is specific for an anti-hepatitis E virus ("HEV") or equivalent thereof. The method comprises contacting a biological sample(s) from the subject with a mixture of HEV specific immunog...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention provides a point of care test ("POCT") for detecting IgA in a subject that is specific for an anti-hepatitis E virus ("HEV") or equivalent thereof. The method comprises contacting a biological sample(s) from the subject with a mixture of HEV specific immunogenic components; and determining the presence of a complex that forms between a binding partner in the biological sample and a HEV specific immunogenic component; and characterizing the binding partner in the complex with an anti-IgA antibody conjugated with gold colloid using reverse flow technology. |
---|